WIRED magazine featured Innophore’s innovative approach to computational drug discovery, highlighting how the company’s Catalophore technology uses 3D point-cloud representations of protein cavities to identify hidden enzymatic functions and potential drug targets — an approach that proved particularly valuable during the rapid response to emerging SARS-CoV-2 variants.